Comprehensive Study Notes on Principles of Medical Laboratory Science

Anatomical Pathology Laboratory & Subspecialties

• Definition & Scope of Anatomical Pathology

  • Anatomical pathology is a major branch of laboratory medicine focused on the study and diagnosis of diseases through the microscopic, structural, and morphological examination of body tissues, organs, and cells.
  • Distinction from Clinical Pathology: Unlike clinical pathology, which analyzes body fluids (such as blood and urine), anatomical pathology emphasizes structural and morphological changes that occur in solid tissues and cellular specimens as a result of disease.

• Laboratory Processing & Microscopic Examination

  • Tissues obtained from patients are carefully processed, preserved, and stained prior to microscopic evaluation.
  • Microscopic analysis allows pathologists to identify abnormalities including inflammation, infection, tumors, and degenerative changes, providing a definitive diagnosis for cancers and other serious clinical conditions.
  • Specimen Processing Steps:
    • Fixation: Preserving tissue structures using chemical fixatives.
    • Processing: Dehydrating and clearing the tissue.
    • Embedding: Enclosing tissue in paraffin wax blocks for support.
    • Sectioning: Cutting extremely thin slices of tissue using a microtome.
    • Staining: Applying microscopic dyes to highlight cellular structures.

• Subspecialties of Anatomical Pathology

  • Surgical Pathology: Examines tissues removed during surgical procedures (e.g., excised tumors, resected organs) to determine the presence, type, and extent of disease.
  • Histopathology: Studies detailed tissue architecture and structural cellular details using prepared microscopic slides.
  • Cytopathology: Focuses on the examination of individual cells or small clusters of cells, often harvested from body fluids or obtained via fine needle aspiration (e.g., Papanicolaou/Pap smear).
  • Autopsy Pathology: Investigates the cause and mechanism of death by examining tissues and organs postmortem.
  • Forensic Pathology: Applies pathological methods to legal and criminal investigations, specifically determining the cause and manner of death.

• Specimen Types Handled

  • Biopsies (small tissue samples).
  • Surgical resections (partially or fully removed organs).
  • Whole organs.
  • Cellular samples obtained through procedures such as Fine Needle Aspiration (FNA).

• Clinical Significance & Applications

  • Confirms clinical diagnoses and determines disease severity.
  • Guides critical treatment decisions, such as cancer staging.
  • Evaluates long-term patient prognosis.
  • Contributes to medical research and education to advance understanding of disease processes.

Specialized Sections of Clinical Pathology

• Immunohistochemistry (IHC)

  • Definition & Mechanism: Diagnostic technique that utilizes labeled antibodies to detect specific antigens (proteins) within tissue samples.
  • Markers & Labels: Antibodies are linked to visible markers such as enzymes, fluorescent dyes, or colloidal gold, enabling visualization under a light or fluorescent microscope.
  • Clinical Applications: Widely used in oncology to identify tumor markers, differentiate benign from malignant tumors, and classify cancer types.
  • Key Tumor Markers in Breast Cancer:
    • $\text{HER2}$ (Human Epidermal Growth Factor Receptor 2)
    • $\text{ER}$ (Estrogen Receptor)
    • $\text{PR}$ (Progesterone Receptor)
  • Advantages: Cost-effective, relatively simple to perform, and offers high diagnostic accuracy.

• Molecular Biology and Biotechnology

  • Scope: Studies biological processes at the molecular level, focusing on $\text{DNA}$, $\text{RNA}$, and proteins that regulate cellular functions.
  • Central Dogma of Molecular Biology: Explains the unidirectional flow of genetic information: $\text{DNA} \rightarrow \text{mRNA} \rightarrow \text{Protein}$.
  • Key Laboratory Techniques:
    • Electrophoresis: Separates $\text{DNA}$, $\text{RNA}$, or proteins based on molecular size and charge.
    • Polymerase Chain Reaction (PCR): Enzymatically amplifies trace amounts of target $\text{DNA}$ sequences into millions of copies for analysis.
    • Restriction Digest: Uses restriction enzymes to cut $\text{DNA}$ molecules at specific nucleotide recognition sequences.
    • Ligation: Joins distinct $\text{DNA}$ fragments using ligase enzymes.
    • Blotting: Detects specific biomolecules (Southern blot for $\text{DNA}$, Northern blot for $\text{RNA}$, Western blot for proteins) using labeled molecular probes or antibodies.
    • Cloning: Introduces specific genes into host cells to facilitate functional studies or mass production of biological molecules.

• Endocrinology

  • Definition: Study of hormones, which act as chemical messengers circulating through the bloodstream to regulate vital physiologic functions including growth, metabolism, mood, and stress response.
  • Endocrine Glands: Endogenous structures that secrete hormones directly into circulation, including the pituitary gland, thyroid gland, and adrenal glands.

• Toxicology

  • Definition: Study of the adverse biological effects of chemicals and physical agents on living organisms across organ, cellular, and biochemical levels.
  • Spectrum of Effects: Ranges from acute (immediate onset) to chronic (long-term accumulation and subtle biochemical changes leading to disease).
  • Key Toxicology Terminology:
    • Toxicants: Any substances (chemical or physical in nature) that produce adverse biological effects of any kind.
    • Toxins: Specific biological proteins produced by living organisms that exhibit adverse effects, usually immediate (e.g., mushroom toxins, tetanus toxin).
    • Poisons: Toxicants or agents that cause immediate illness or death when introduced in extremely small amounts.
  • Toxic Agent vs. Chemical Compound Comparison:
    • Toxic Agent Definition: Any factor (chemical, physical, or biological) capable of causing harm.
    • Chemical Compound Definition: A distinct chemical substance causing specific physiological alterations.
    • Scope: Toxic agents include chemical, physical, or biological entities (e.g., bacteria); chemical compounds are purely chemical.
    • Examples: Cyanide and mercury serve as classic toxic chemical agents.
  • The Dose-Response Relationship (Paracelsus Principle):
    • Established by Paracelsus, stating that specific chemicals are responsible for poison toxicity and that the physiological effect depends entirely on the dose ingested or absorbed.
    • Small doses may be completely harmless or therapeutic, whereas large doses of the exact same substance become toxic or lethal.

The Laboratory Testing Cycle

• Overview

  • A continuous, interconnected workflow comprising three distinct phases: Pre-Analytical, Analytical, and Post-Analytical. An error in any single phase compromises patient care and invalidates the entire testing process.

• 1. Pre-Analytical Phase (Before Testing)

  • Scope: Begins when a laboratory test is ordered by a clinician and ends when the prepared specimen is ready for testing in the laboratory.
  • Error Susceptibility: Documented as the most error-prone stage of the entire laboratory testing cycle.
  • Essential Procedures:
    • Proper and complete filling out of test request forms.
    • Accurate patient identification using a minimum of two unique patient identifiers.
    • Appropriate patient preparation (e.g., fasting requirements, medication withholding, specific timing of collection).
    • Correct specimen collection techniques using appropriate containers and additives.
    • Immediate and accurate labeling of specimens at the patient's bedside or collection site.
    • Proper handling, temperature-controlled storage, and timely transportation of samples.
  • Common Pre-Analytical Errors:
    • Mislabeled or completely unlabeled specimen containers.
    • Hemolyzed, lipemic, or contaminated blood samples.
    • Delayed transport leading to sample degradation or altered analyte stability.

• 2. Analytical Phase (During Testing)

  • Scope: Involves the actual physical, chemical, or microscopic testing of the specimen using standardized methods and analytical instruments.
  • Essential Procedures:
    • Proper sample preparation prior to analysis (e.g., centrifugation, aliquoting).
    • Strict execution of analytical testing following standard operating procedures (SOPs).
    • Utilization of calibrated, well-maintained laboratory instrumentation.
    • Routine execution and monitoring of quality control (QC) procedures.
    • Strict adherence to overarching quality assurance protocols.
  • Common Analytical Errors:
    • Instrument malfunction, mechanical failure, or improper calibration.
    • Incorrect reagent reconstitution, degradation, or use of expired reagents.
    • Non-compliance with established testing SOPs by laboratory personnel.

• 3. Post-Analytical Phase (After Testing)

  • Scope: Begins once testing yields valid numerical or qualitative data and encompasses result verification, reporting, and interpretation.
  • Essential Procedures:
    • Verification and technical validation of analytical test results.
    • Accurate transcription, recording, and electronic data entry into laboratory information systems (LIS).
    • Interpretation of findings relative to established biological reference ranges.
    • Timely transmission and reporting of results to attending healthcare providers (including critical/panic values).
    • Proper archival, storage, documentation, and safe biohazardous disposal of analyzed specimens.
  • Common Post-Analytical Errors:
    • Delayed communication or failure to report critical results.
    • Data entry or manual transcription errors.
    • Misinterpretation of laboratory findings by clinical staff.

Laboratory Safety, Biosafety, and Facility Rules

• Sharps Safety Protocols

  • Hypodermic needles must NEVER be recapped, clipped, bent, broken, or removed from disposable syringes by hand after use.
  • Used sharps must be disposed of immediately in puncture-resistant, rigid sharps containers fitted with proper covers.
  • Sharps must be handled with extreme caution to prevent accidental needlestick injuries and bloodborne pathogen transmission.

• Chemical Safety Protocols

  • All chemical reagent containers must be clearly labeled and stored according to chemical compatibility guidelines.
  • Personal Protective Equipment (PPE) including safety goggles, gloves, and lab coats must be worn during chemical handling.
  • Direct inhalation, ingestion, or skin contact with hazardous chemicals must be strictly avoided.
  • Personnel must be familiar with Safety Data Sheets (SDS) / Material Safety Data Sheets (MSDS).
  • Volatile and toxic chemical reagents must only be handled inside working chemical fume hoods with proper ventilation.

• Fire Safety Protocols

  • Keep all flammable compounds and solvents stored away from open heat sources or electrical sparks.
  • Know the exact locations and operational methods for fire extinguishers, fire blankets, and manual pull alarms.
  • Avoid overloading electrical circuits or operating damaged electrical gear.
  • Follow established calm evacuation routes during emergency fire alarms.

• Electrical Safety Protocols

  • Inspect electrical cords and instruments for frayed wires or exposed conductors prior to operation.
  • Keep electrical hardware isolated from water sources or wet countertops.
  • Never manipulate electrical switches or plugs with wet hands.
  • Turn off and disconnect equipment from power outlets prior to servicing or when not in use.

• Radiation Safety Protocols

  • Adhere strictly to the ALARA principle: $\text{ALARA} = \text{As Low As Reasonably Achievable}$.
  • Minimize exposure using the three primary controls: shielding, distance, and time control.
  • Wear personal radiation dosimeters when working in designated radiation areas.
  • Restricted exclusively to certified, trained radiation personnel.

• General Laboratory Code of Practice & Facility Operating Guidelines

  • Mouth Pipetting: Strictly forbidden under any circumstances; mechanical pipetting devices must be used.
  • Personal Hygiene: Placing materials or fingers in the mouth is prohibited. Licking labels or stamps is banned. Eating, drinking, smoking, applying cosmetics, and manipulating contact lenses are strictly prohibited in technical work areas.
  • Food Storage: Storing food or beverages in laboratory refrigerators, freezers, or countertops is completely forbidden.
  • Aerosol Minimization: All technical operations (e.g., centrifugation, vortexing, sonicating, streaking agar) must be performed using techniques that minimize aerosol and droplet production.
  • Accident & Spill Reporting: All biological or chemical spills, overt exposures, or potential contamination incidents must be reported immediately to the laboratory supervisor. A written incident log must be documented and maintained.
  • Document Protection: Written records or files meant for removal from the facility must be protected from physical contamination while inside the laboratory.
  • Facility Access & Security:
    • Access is restricted exclusively to authorized personnel.
    • Laboratory entrance doors must be kept continuously closed.
    • Children are prohibited from entering laboratory work spaces.
    • Access to animal housing areas requires specialized authorization; no unauthorized animals are permitted.
    • The international biohazard warning symbol must be clearly posted on access doors where Risk Group 2 or higher biological agents are handled.
  • Personal Protective Equipment (PPE) & Dress Code:
    • Clean lab coats, gowns, or uniforms must be worn continuously while in work zones.
    • Protective footwear must cover the entire foot; open-toed shoes are prohibited.
    • Protective eyewear (goggles, face shields) must be worn whenever risk of splashes, flying particles, or artificial ultraviolet radiation exists.
    • Protective clothing must be removed prior to exiting the laboratory (e.g., visiting lunchrooms, offices, libraries, or restrooms).

• PPE Donning and Doffing Sequences

  • Donning Sequence (Putting on PPE):
    1. Hand Hygiene
    2. Gown
    3. Mask / Respirator
    4. Goggles / Face Shield
    5. Gloves
  • Doffing Sequence (Removing PPE):
    1. Gloves
    2. Goggles / Face Shield
    3. Gown
    4. Mask / Respirator
    5. Hand Hygiene
  • Note on Doffing: Remove PPE at the doorway or outside the client room. If hands become contaminated during doffing, stop immediately, perform hand hygiene, and resume removal.

Biosafety Levels, Risk Groups, and Laboratory-Acquired Infections

• History of Biosafety and Biosecurity

  • April 18, 1955: The American Biological Safety Association (ABSA) held its initial unofficial meeting at Camp Detrick (now Fort Detrick), involving military personnel from Camp Detrick, Pine Bluff Arsenal, and Dugway Proving Grounds, focusing on biological warfare safety.
  • 1964–1965: The National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) joined formal safety discussions.
  • 1966: Participation expanded to academic institutions, private industry, and hospitals.
  • 1973–1974: OSHA regulations were evaluated for lab safety. In 1974, the U.S. Postal Service and Department of Transportation published formal regulations for transporting etiologic agents.
  • Mid-1970s: Formal introduction of the four Biosafety Levels ($\text{BSL-1}$ to $\text{BSL-4}$) and recombinant $\text{DNA}$ safety guidelines.
  • 1984 Rajneeshee Bioterror Attack: Members of the Rajneeshee commune in The Dalles, Oregon, deliberately contaminated 10 restaurant salad bars with Salmonella (purchased legally from a medical supplier), sickening over 750 individuals.
  • 2001 Anthrax Mailings (Amerithrax): Three weeks post-September 11, anthrax spores (Bacillus anthracis) mailed to U.S. Senators and media figures resulted in 22 infections and 5 deaths. Genetic analysis confirmed the spores originated from a single batch of the Ames strain (isolated from a Texas cow). On February 19, 2010, the FBI, DOJ, and Postal Inspection Service formally concluded that Dr. Bruce Ivins, a USAMRIID scientist, acted alone in the attack.
  • October 2003: The National Research Council released the "Fink Report" (Biotechnology Research in an Age of Terrorism), establishing policy to balance biological research with national security.

• Key Definitions in Biorisk Management

  • Biosafety: Containment principles, facility designs, equipment, and practices executed to prevent unintentional exposure or accidental release of biological agents and toxins.
  • Biosecurity: Protection, control, and accountability measures applied to biological materials and information to prevent unauthorized access, theft, misuse, or intentional release.
  • Biohazard: A biological agent or source of harm.
  • Biorisk: The probability/chance of occurrence combined with the severity of harm resulting from biological hazards.
  • Hazard: An inherent source or potential cause of harm (exists regardless of exposure).
  • Threat: The potential or likelihood for intentional harm, misuse, theft, or deliberate release by an adversary.
  • Adversary: An individual with malicious intent.
  • Insider vs. Outsider: Authorized individual within an institution vs. unauthorized external person.
  • Incident: An event or exposure that has the potential to cause harm.

• Classification of Biological Risk Groups

  • Risk Group 1 (No or Low Individual and Community Risk): Microorganisms unlikely to cause human or animal disease. Examples: Escherichia coli K-12, Saccharomyces cerevisiae, Lactobacillus, Bacillus subtilis.
  • Risk Group 2 (Moderate Individual Risk, Low Community Risk): Pathogens that cause human or animal disease, but effective treatments and preventive measures are available; environmental spread risk is low. Examples: Streptococcus, Herpes virus, mammalian cell lines.
  • Risk Group 3 (High Individual Risk, Low Community Risk): Pathogens that cause serious human or animal disease, often airborne, but do not ordinarily spread from person to person. Effective treatments/vaccines usually exist. Examples: Yersinia pestis, Human Immunodeficiency Virus (HIV), Severe Acute Respiratory Syndrome (SARS) virus.
  • Risk Group 4 (High Individual and Community Risk): Pathogens that cause severe to fatal human or animal disease, readily transmitted between individuals. Effective treatment or vaccines are usually unavailable. Examples: Ebola virus, Marburg virus, Lassa virus.

• Biosafety Levels (BSL) Summary

  • BSL-1: Basic laboratory setting; handles non-pathogenic organisms on open benches; minimal containment required.
  • BSL-2: Handles moderate-risk pathogens (e.g., Salmonella); requires PPE, biosafety cabinets (BSC), biohazard signs, and limited access.
  • BSL-3: Containment laboratory; handles indigenous/exotic airborne pathogens causing serious disease; requires biosafety cabinets, controlled access, directional airflow, and specialized ventilation systems.
  • BSL-4: Maximum containment facility; handles high-risk exotic pathogens; requires full-body positive pressure air-supplied suits or Class III biosafety cabinets, isolation building, and complex air/waste decontamination systems.

• Non-Biohazardous Materials

  • Biological materials that do not pose an infection or harm risk under standard handling. Examples include non-pathogenic microbes, non-primate animals and plants, and biologically derived non-toxic substances (e.g., isolated proteins or purified enzymes).

• Laboratory-Acquired Infections (LAIs)

  • Common Transmission Routes: Ingestion, aerosol inhalation, percutaneous inoculation (needlesticks), and contact with contaminated mucous membranes or broken skin.
  • Enteric Infections: Caused by ingestion of contaminated food, water, or aerosolized droplets in the lab. Key causative organisms: Salmonella, Shigella, Escherichia coli, Giardia lamblia (protozoan), Rotavirus, and Norovirus.
  • Pharyngitis: Most commonly caused by Streptococcus pyogenes via aerosol inhalation or direct contact with clinical exudates/sputum.
  • Cellulitis: Deep tissue bacterial infection caused by Streptococcus, Staphylococcus, Haemophilus influenzae, Pneumococcus, and Clostridium species following exposure to infected fluids or tissues.
  • Conjunctivitis: Ocular membrane inflammation resulting from splashes or touching eyes with contaminated fingers. Caused by Staphylococcus, Streptococcus, Adenovirus, or fungi.

Biorisk Management and the AMP Model

• Fundamental Principles of Biorisk Management

  • Modern biorisk management integrates biosafety and biosecurity into a unified organizational framework that aligns with international standards such as ISO 35001:2019 (Biorisk Management for Laboratories).
  • Addresses the limitations of traditional checklist systems that relied solely on rigid Biosafety Levels or assigned responsibility exclusively to biosafety officers without executive authority.
  • Emphasizes top management accountability and institutional continuous improvement.

• Mathematical Definition and Characteristics of Risk

  • Risk is defined as a function of likelihood and severity of consequences:     $\text{Risk} = \text{Likelihood} \times \text{Consequences}$
  • Characteristics: Dynamic (changes over time), context-specific, can be evaluated qualitatively or quantitatively, and can be mitigated but rarely eliminated completely.

• The AMP Model

  • 1. Assessment (Biorisk Assessment):
    • Systematic identification of biological hazards and threats.
    • Risk Characterization: Evaluates specific exposure scenarios by analyzing organism type, transmission route, disease severity, and current procedures.
    • Risk Evaluation: Judges whether identified risks are acceptable or intolerable based on institutional guidelines, resources, personnel skill, and regulatory standards.
  • 2. Mitigation (Biorisk Mitigation):
    • Actionable measures implemented to reduce or eliminate acceptable/unacceptable risks.
    • Engineering Controls: Physical barriers (e.g., Biosafety Cabinets, HEPA filtration, negative pressure rooms).
    • Administrative Controls: Protocols, SOPs, access policies, annual safety training.
    • Personal Protective Equipment (PPE): Respirators, gloves, lab coats, face shields.
    • Decontamination & Waste Management: Autoclaving, chemical treatment.
  • 3. Performance (Performance Evaluation):
    • Ensures continuous system efficacy using the Plan-Do-Check-Act (PDCA) continuous improvement cycle.
    • Includes monitoring SOP compliance, auditing safety protocols, reviewing near-misses, and investigating accidents.

Healthcare Waste Management and Color Coding

• Benefits of Healthcare Waste Management

  • Breaks infection chains, preventing environmental pathogen spread.
  • Controls nosocomial (hospital-acquired) diseases.
  • Reduces community exposure to multi-drug resistant strains.
  • Prevents bloodborne viral transmission (HIV, Hepatitis B, Hepatitis C) from needlestick injuries.
  • Prevents toxic emission damage (dioxins, furans, mercury exposure).

• Philippine Department of Health (DOH) Color Coding Scheme for Waste

  • Yellow: Infectious and Pathological Waste (e.g., blood-soaked dressings, culture plates, tissue resections). Treated via autoclaving or incineration prior to disposal.
  • Red: Sharps Waste (e.g., needles, syringes, scalpel blades, broken glass). Must be collected in rigid, puncture-resistant safety boxes.
  • Black: Dry General Non-Hazardous Waste (e.g., office paper, unsoiled packaging materials).
  • Green: Wet Non-Infectious Biodegradable Waste (e.g., food scraps, kitchen waste).
  • Blue: Recyclable Non-Hazardous Waste (e.g., uncontaminated plastic bottles, paperboard, clean glass containers).
  • Yellow with Black Stripe: Chemical and Pharmaceutical Waste (e.g., expired medicines, diagnostic reagents, heavy metals). Disposed of by specialized accredited TSD facilities.

• Methods of Healthcare Waste Treatment

  • 1. Incineration: High-temperature dry burning between $1,800\,^\circ\text{F}$ and $2,000\,^\circ\text{F}$ ($982\,^\circ\text{C}$ to $1093\,^\circ\text{C}$). Reduces waste volume by $90\%$ to $95\%$. Disadvantage: Releases carcinogenic emissions (dioxins and furans).
  • 2. Autoclaving (Steam Sterilization): Disinfection using saturated high-pressure steam at $121\,^\circ\text{C}$. Suitable for approximately $90\%$ of infectious medical waste. Unsuitable for pathological, cytotoxic, or chemical waste.
  • 3. Gas Sterilization: Employs chemical gases like ethylene oxide or formaldehyde. Highly toxic, flammable, and carcinogenic.
  • 4. Chemical Disinfection: Applies agents like sodium hypochlorite, hydrogen peroxide, or quaternary ammonium compounds to liquid waste (blood, urine).
  • 5. Microwave Treatment: Uses microwave radiation combined with internal moisture and heat after waste shredding and moistening. Handles $\approx 90\%$ of infectious waste.
  • 6. Irradiation: Applies gamma radiation from Cobalt-60 ($^{60}\text{Co}$) sources to destroy pathogen $\text{DNA}$. Unsuitable for pathological waste due to high costs.
  • 7. Thermal Inactivation: Heats liquid waste streams to specific lethal temperatures for set durations prior to discharge into municipal sewer systems.

• The Universal Biohazard Symbol

  • Designed in the 1960s by Charles Baldwin and Dow Chemical Company.
  • Features a distinct three-crescent symmetrical geometric pattern forming a central circle.

Healthcare Waste Management Legislation and Policies

• International Environmental Treaties

  • Montreal Protocol (1987): Enforced January 1, 1989; targets the global phaseout of ozone-depleting substances.
  • Basel Convention (1989): Controls transboundary movements of hazardous wastes, requiring strict export permissions.
  • UN Framework Convention on Climate Change (UNFCCC) (1992): International agreement to curb greenhouse gas emissions.
  • Stockholm Convention (2001): Global agreement to restrict or eliminate Persistent Organic Pollutants (POPs)—bioaccumulative, toxic, persistent chemicals.
  • ASEAN Framework Agreement on Goods in Transit (1998): Incorporates Protocol 9 on Dangerous Goods, regulating transit of toxic and infectious substances.

• Philippine National Laws and Administrative Orders

  • Republic Act No. 4226 "Hospital Licensure Act" (1965): Mandates registration and licensing of all Philippine hospitals by the DOH.
    • DOH AO No. 70-A s. 2002: Mandates submission of waste management plans.
    • DOH AO No. 2005-0029: Requires a formal Healthcare Waste Management Plan as a prerequisite for License to Operate (LTO).
    • DOH AO No. 2007-0027: Requires written waste disposal SOPs and biosafety/biosecurity policies for clinical laboratories.
  • Republic Act No. 6969 "Toxic Substances and Hazardous and Nuclear Wastes Control Act of 1990": Regulates chemical generators, transporters, and Treatment, Storage, and Disposal (TSD) facilities.
    • DENR AO No. 36 s. 2004: Procedural manual for RA 6969 comprising 10 sections.
    • DOH-DENR Joint AO No. 02 s. 2005: Harmonizes DOH and DENR oversight of medical waste handling.
    • DOH AO 2007-0014: Requires Certificate of Product Registration (CPR) for waste treatment equipment.
  • Republic Act No. 8749 "Philippine Clean Air Act of 1999": Explicitly prohibited incineration of biomedical waste effective July 17, 2003, mandating non-burn treatment technologies.
  • Republic Act No. 9003 "Ecological Solid Waste Management Act of 2000": Mandates point-of-source waste segregation.
  • Republic Act No. 9275 "Philippine Clean Water Act of 2004": Regulates liquid effluent discharge into bodies of water.
  • Presidential Decree No. 856 "Code on Sanitation of the Philippines" (1998): Regulates sewage collection, excreta disposal, and refuse handling.
    • AO 2010-0033 (Chapter XXI): Requires placing human remains deceased from communicable diseases into airtight plastic cadaver bags with biohazard tags, prohibiting open viewing prior to burial or cremation.
  • Presidential Decree No. 984 "Pollution Control Law" (1976): Governs industrial/institutional air and water pollution discharges. Supported by DENR AO 34 (Water Quality Criteria), DENR AO 35 (Effluent Standards), and DENR AO 26 s. 1992 (mandating designation of accredited Pollution Control Officers / PCOs).
  • Presidential Decree No. 1586 (1978): Requires an Environmental Compliance Certificate (ECC) prior to constructing or expanding healthcare facilities.
  • Executive Order No. 301 (2004): Establishes Green Procurement Programs across government agencies.
  • DOH AO No. 2008-0021: Mandates the gradual phaseout of mercury-containing devices (thermometers, sphygmomanometers) in healthcare facilities.
  • BFAD MC No. 22 s. 1994 & BC No. 16 s. 1999: Orders the destruction of used pharmaceutical vials and bottles to eliminate counterfeit drug repackaging.

Quality Assurance and Quality Control in Laboratory Testing

• Definitions and Core Concepts

  • Total Quality Management (TQM): A total organizational management approach consisting of five elements: Quality Laboratory Process (QLP), Quality Control (QC), Quality Assessment (QA), Quality Improvement (QI), and Quality Planning (QP).
  • Quality Assessment (QA): Comprehensive program monitoring pre-analytical, analytical, and post-analytical phases to ensure accurate, valid patient results.
  • Accuracy: Closeness of a measured test result to the true target value.
  • Precision: Reproducibility; closeness of agreement between repeated independent measurements.
  • Reliability: The ability of an analytical procedure to maintain accuracy and precision over extended periods.
  • Standards vs. Controls:
    • Standard: A solution of known, highly accurate concentration (traceable to National Institute of Standards and Technology / NIST) used to calibrate instruments or construct standard curves.
    • Control: A specimen mimicking patient matrix with an established target value analyzed alongside patient samples.
    • Assayed Control: Values and acceptable ranges assigned by the manufacturer.
    • Unassayed Control: Values and ranges determined independently by the analyzing laboratory.
  • Six Sigma: Data-driven performance improvement strategy targeting process optimization.
  • Lean Principles: Focuses on streamlining workflows and eliminating non-value-added operational waste.
  • ISO 9000 Standards: International criteria for quality management systems established by the International Organization for Standardization.

• Statistical Analysis Formulas in Quality Control

  • Arithmetic Mean ($\bar{x}$): Sum of individual values ($x_i$) divided by total number of values ($n$):     $\bar{x} = \frac{\sum x_i}{n}$
  • Median: Middle numeric value when data set is arranged by magnitude.
  • Mode: Most frequently occurring value in a data set.
  • Standard Deviation ($s$): Quantifies dispersion around the mean:     $s = \sqrt{\frac{\sum (x_i - \bar{x})^2}{n - 1}}$
  • Variance ($s^2$): Square of standard deviation.
  • Coefficient of Variation (CV): Relative measure of precision expressed as a percentage:     $\text{CV} = \left( \frac{s}{\bar{x}} \right) \times 100\%$
  • Normal Distribution Curve: Symmetric bell-shaped distribution where $95.45\%$ of all values lie within $\pm 2s$ ($\bar{x} \pm 2s$).
  • Sensitivity: Percentage of individuals with a disease who correctly test positive:     $\text{Sensitivity} = \left( \frac{\text{True Positives}}{\text{True Positives} + \text{False Negatives}} \right) \times 100\%$
  • Specificity: Percentage of disease-free individuals who correctly test negative:     $\text{Specificity} = \left( \frac{\text{True Negatives}}{\text{True Negatives} + \text{False Positives}} \right) \times 100\%$
  • Positive Predictive Value (PPV): Percentage of positive test results that are true positives.
  • Negative Predictive Value (NPV): Percentage of negative test results that are true negatives.

• Establishing Reference Intervals

  • Constructed as $\bar{x} \pm 2s$, encompassing $95\%$ of healthy individuals.
  • Verification: Requires a minimum of 20 healthy individual samples to verify manufacturer ranges.
  • Establishment: Prefers a minimum of 120 healthy individuals per demographic (age, biological sex) category.

• Internal Quality Control Evaluation (Levey-Jennings & Westgard Rules)

  • Levey-Jennings Chart: Plotting daily QC values against $\bar{x} \pm 1s$, $\bar{x} \pm 2s$, and $\bar{x} \pm 3s$ limits.
  • Trend: Gradual movement of control values in one direction away from the mean over 6 or more consecutive runs (indicates reagent deterioration or dirty optics).
  • Shift: Sudden, abrupt shift of 6 or more consecutive control values onto one side of the mean (indicates new lot calibration error, bulb change, or sudden reagent change).
  • Westgard Multirule Definitions:
    • $1_{2s}$: One control value exceeds $\bar{x} \pm 2s$. Warning rule only; does not reject the run.
    • $1_{3s}$: One control value exceeds $\bar{x} \pm 3s$. Rejection rule; detects random error.
    • $2_{2s}$: Two consecutive control values exceed the same $\bar{x} + 2s$ or $\bar{x} - 2s$ limit. Rejection rule; detects systematic error.
    • $R_{4s}$: One control in a run exceeds $\bar{x} + 2s$ and another exceeds $\bar{x} - 2s$ (creating a $4s$ spread). Rejection rule; detects random error.
    • $4_{1s}$: Four consecutive control values exceed $\bar{x} + 1s$ or $\bar{x} - 1s$ on the same side of the mean. Rejection rule; detects systematic error.
    • $10_x$: Ten consecutive control values fall on one side of the mean. Rejection rule; detects systematic error.

• External Quality Control (Proficiency Testing)

  • Required by federal CLIA '88 regulations for clinical laboratories reporting human diagnostic data.
  • Unknown samples are supplied by external accredited agencies (e.g., CAP, AAB) and analyzed using normal clinical workflows.
  • Youden Plot: Graphical method analyzing inter-laboratory proficiency results across two runs or two sample concentrations to distinguish within-lab vs. between-lab variations.
  • Designated National Reference Laboratories in the Philippines:
    • National Kidney and Transplant Institute (NKTI): Hematology and Coagulation.
    • Research Institute for Tropical Medicine (RITM): Microbiology and Parasitology.
    • Lung Center of the Philippines (LCP): Clinical Chemistry.
    • East Avenue Medical Center (EAMC): Toxicology / Drug of Abuse testing.
    • San Lazaro Hospital STD-AIDS Cooperative Center Laboratory (SACCL): Infectious Immunology ($\text{HBsAg}$, $\text{HIV}$, $\text{HCV}$).

Professional Organizations in Medical Laboratory Science

• Role and Function of Professional Organizations

  • Professional bodies provide opportunities for networking, continuing professional development (CPD), research publication, public policy representation, and professional advocacy.
  • APO / AIPO Requirement: In the Philippines, membership in an Accredited Professional Organization (APO) or Accredited Integrated Professional Organization (AIPO) accredited by the Professional Regulation Commission (PRC) and Professional Regulatory Board (PRB) is mandatory for professional hiring, retention, and license renewal.

• Types of Professional Organizations

  • 1. Accrediting Organizations: Accredit curricular programs offered by higher education institutions via peer-review visits.
    • PAASCU: Philippine Accrediting Association of Schools, Colleges, and Universities.
    • PACUCOA: Philippine Association of Colleges and Universities Commission on Accreditation.
    • AACUP: Accrediting Agency of Chartered Colleges and Universities in the Philippines, Inc.
    • AUN: ASEAN University Network.
  • 2. Credentialing / Certifying Organizations: Administer professional certification examinations.
    • AMT: American Medical Technologists.
    • ASCP: American Society for Clinical Pathology.
    • ISCLT: International Society for Clinical Laboratory Technology.
    • NCA: National Credentialing Agency for Laboratory Personnel.
  • 3. Professional Societies: Organizations fostering CPD, education, research, and professional advancement.
    • Local Societies (Philippines):
      • PAMET: Philippine Association of Medical Technologists, Inc. (The sole APO for Registered Medical Technologists in the Philippines).
      • PASMETH: Philippine Association of Schools of Medical Technology and Public Health, Inc. (National organization representing MLS academic institutions, Deans, and instructors).
      • BRAP: BioRisk Association of the Philippines.
      • PBCC: Philippine Blood Coordinating Council.
      • PCQACL: Philippine Council for Quality Assurance in Clinical Laboratories.
      • PhBBA: Philippine Biosafety and Biosecurity Association.
    • International Societies:
      • ASCP: American Society for Clinical Pathology.
      • AMT: American Medical Technologists.
      • AACLS: ASEAN Association of Clinical Laboratory Sciences.
      • ADLM: Association for Diagnostics & Laboratory Medicine.
      • ASCLS: American Society for Clinical Laboratory Science.
      • IFBLS: International Federation of Biomedical Laboratory Science.
      • IFCC: International Federation of Clinical Chemistry and Laboratory Medicine.
      • APFCB: Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine.
      • CLMA: Clinical Laboratory Management Association.